{
    "clinical_study": {
        "@rank": "95755", 
        "arm_group": {
            "arm_group_label": "Transcranial electrical stimulation", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Transcranial electrical stimulation (TES) techniques offer a novel treatment approach for\n      depression and have shown promising efficacy. However, there is no published data to date on\n      their effectiveness as a maintenance treatment. This study will investigate ways of using\n      TES as a maintenance treatment to prevent relapse in depression."
        }, 
        "brief_title": "Maintenance Transcranial Electrical Stimulation for Depression", 
        "condition": [
            "Major Depressive Disorder", 
            "Bipolar Disorder"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bipolar Disorder", 
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All participants will be \u2265 18 years old.\n\n          -  Participants must have experienced a significant clinical response, defined as \u2265 50%\n             decrease from baseline scores on the Montgomery Asberg Depression Rating Scale\n             (MADRS).\n\n        Exclusion Criteria:\n\n          -  Inadequate response to acute trial of TES.\n\n          -  Suicidality.\n\n          -  Clinically defined neurological disorder or insult.\n\n          -  Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash)\n             at proposed electrode sites.\n\n          -  Pregnancy (women of childbearing age will be asked to undergo a urine pregnancy test\n             prior to starting the study).\n\n          -  Concurrent long acting benzodiazepines, ritalin or dexamphetamine medication.\n\n          -  Treatment for depression is changed during months 3-9 of the trial."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01890356", 
            "org_study_id": "HC12499"
        }, 
        "intervention": {
            "arm_group_label": "Transcranial electrical stimulation", 
            "intervention_name": "Transcranial electrical stimulation", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Depression", 
            "Treatment", 
            "Transcranial electrical stimulation", 
            "Maintenance"
        ], 
        "lastchanged_date": "May 30, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Randwick, Sydney", 
                    "country": "Australia", 
                    "state": "New South Wales", 
                    "zip": "2031"
                }, 
                "name": "Black Dog Institute / University of New South Wales"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Study of Transcranial Electrical Stimulation (TES) as a Maintenance Treatment for Depression", 
        "overall_contact": {
            "email": "a.alonzo@unsw.edu.au", 
            "last_name": "Angelo Alonzo, PhD", 
            "phone": "61-2-93823720"
        }, 
        "overall_contact_backup": {
            "email": "donel.martin@unsw.edu.au", 
            "last_name": "Donel Martin, PhD", 
            "phone": "61-2-93829261"
        }, 
        "overall_official": {
            "affiliation": "University of New South Wales", 
            "last_name": "Colleen Loo, MBBS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Australia: Department of Health and Ageing Therapeutic Goods Administration", 
                "Australia: Human Research Ethics Committee"
            ]
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "June 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Montgomery Asberg Depression Rating Scale for Depression (MADRS)", 
            "safety_issue": "No", 
            "time_frame": "9 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01890356"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The University of New South Wales", 
            "investigator_full_name": "Colleen Loo", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "The University of New South Wales", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The University of New South Wales", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}